Systematic analysis of 18 CYP3A4 sensitive substrate drugs (AUC ratio attributable to hepatic CYP3A4 inhibition greater than 3-fold) revealed no apparent relationship between the severity of CKD and CYP3A4-mediated clearance [7]. Here, CYP3A4 is linked to chronic kidney disease.